Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Not applicableStudy completedNCT00006342
What this trial is testing

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
Duke University 19
Testing effectiveness (Phase 2)Ended earlyNCT02353572
What this trial is testing

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
University of Colorado, Denver 3
Testing effectiveness (Phase 2)Ended earlyNCT00432419
What this trial is testing

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Who this might be right for
HIV InfectionsLymphoma, Non-Hodgkin
French National Agency for Research on AIDS and Viral Hepatitis 1
Not applicableUnknownNCT02172365
What this trial is testing

Allogeneic SCT for CML, TKI Failure After TKI Failure

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 350
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Not applicableStudy completedNCT00340392
What this trial is testing

Isolation and Characterization of Mammary Stem Cells

Who this might be right for
Stem Cells
National Cancer Institute (NCI) 400
Not applicableStudy completedNCT00923377
What this trial is testing

Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT00882895
What this trial is testing

Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Study completedNCT02089919
What this trial is testing

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Who this might be right for
Neoplasms, Liver
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Study completedNCT00083135
What this trial is testing

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 18
Testing effectiveness (Phase 2)UnknownNCT03337919
What this trial is testing

ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University College, London 78
Testing effectiveness (Phase 2)Study completedNCT00167219
What this trial is testing

Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

Who this might be right for
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota 15
Not applicableLooking for participantsNCT05444712
What this trial is testing

Transplantation After Complete Response In Patients With T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Hospices Civils de Lyon 204
Early research (Phase 1)Study completedNCT01074060
What this trial is testing

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
City of Hope Medical Center 18
Not applicableLooking for participantsNCT06155188
What this trial is testing

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

Who this might be right for
LeukemiaStem Cell TransplantCord Blood
Nanfang Hospital, Southern Medical University 60
Large-scale testing (Phase 3)Study completedNCT00008203
What this trial is testing

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04044560
What this trial is testing

Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaStem Cell LeukemiaMinimal Residual Disease
University of British Columbia 8
Post-approval studies (Phase 4)Study completedNCT01856803
What this trial is testing

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

Who this might be right for
Leukemia, GVHD, ATG, Transplantation
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Next Page